Huntington’s Disease Treatment Market Report 2026
Download Free Sample Buy Now
Huntington’s Disease Treatment Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Huntington’s Disease Treatment Market Report 2026

Global Outlook – By Treatment (Symptomatic Treatment, Disease-Modifying Therapies), By Administration Type (Oral, Intravenous, Subcutaneous, Topical), By Therapeutic (Genetic Disorders, Neurological Disorders, Psychiatric Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Clinics, Homecare Settings, Research Centers) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Huntington’s Disease Treatment Market Overview

• Huntington’s Disease Treatment market size has reached to $0.82 billion in 2025

• Expected to grow to $1.48 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%

• Growth Driver: The Increase In Gene Therapies Is Fueling The Growth Of The Market Due To Their Ability To Target Genetic Causes And Slow Disease Progression

• Market Trend: Advancements In Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Therapies For Huntington's Disease Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Huntington’s Disease Treatment Market?

Huntington’s disease treatment involves medical therapies designed to manage the symptoms of this progressive neurological disorder. The primary goal is to slow disease progression, alleviate symptoms, and enhance the patient’s quality of life.

The main types of Huntington’s disease treatment are symptomatic treatment and disease-modifying therapies. Symptomatic treatment focuses on alleviating Huntington’s disease symptoms and improving quality of life without addressing the underlying cause, and is increasingly in demand as patients seek better management of daily challenges. These treatments can be administered through various methods, including oral, intravenous, subcutaneous, and topical routes for various therapeutic applications, including genetic, neurological, and psychiatric disorders. The treatments are distributed through multiple channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by a range of end users, including hospitals, clinics, home care settings, and research institutions.

Huntington’s Disease Treatment Market Global Report 2026 Market Report bar graph

What Is The Huntington’s Disease Treatment Market Size and Share 2026?

The huntington’s disease treatment market size has grown rapidly in recent years. It will grow from $0.82 billion in 2025 to $0.92 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to limited treatment options for neurodegenerative disorders, increasing diagnosis of genetic neurological diseases, early reliance on symptomatic management, expansion of neurology specialty care, growth in hospital-based neurological treatments.

What Is The Huntington’s Disease Treatment Market Growth Forecast?

The huntington’s disease treatment market size is expected to see rapid growth in the next few years. It will grow to $1.48 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to advancements in gene therapy technologies, rising investment in rare disease research, increasing orphan drug designations, growing precision medicine adoption, expanding pipeline of disease-modifying therapies. Major trends in the forecast period include growing focus on disease-modifying therapies, increasing adoption of gene and RNA-based treatments, expansion of combination therapy approaches, rising emphasis on symptom-specific drug development, increasing clinical trial activity for rare neurological disorders.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Huntington’s Disease Treatment Market Segmentation

1) By Treatment: Symptomatic Treatment, Disease-Modifying Therapies

2) By Administration Type: Oral, Intravenous, Subcutaneous, Topical

3) By Therapeutic: Genetic Disorders, Neurological Disorders, Psychiatric Disorders

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Homecare Settings, Research Centers

Subsegments:

1) By Symptomatic Treatment: Antidepressants, Antipsychotics, Mood Stabilizers, Chorea Medications, Cognitive Enhancers

2) By Disease-Modifying Therapies: Gene Therapy, Neuroprotective Agents, RNA-Based Therapies, Stem Cell Therapy, Protein-Targeting Therapies

What Is The Driver Of The Huntington’s Disease Treatment Market?

The increase in gene therapies is expected to propel the growth of the Huntington’s disease treatment market going forward. Gene therapies are treatments that modify or replace faulty genes to cure or prevent diseases at the genetic level. Gene therapies are growing as precision medicine advances, enabling direct targeting of genetic causes and achieving better outcomes than traditional treatments. Gene therapies treat Huntington’s disease by silencing the defective HTT gene that generates harmful proteins, preventing nerve cell damage. This strategy helps slow disease progression, protect brain function, and offers potential for long-term control. For instance, in July 2023, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, at the end of Q1 2023, there were 247 gene therapies in phase II, but this number rose by 5% to reach 260 by the end of Q2. Therefore, the increase in gene therapies is driving the growth of the Huntington’s disease treatment industry.

Key Players In The Global Huntington’s Disease Treatment Market

Major companies operating in the huntington’s disease treatment market are F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Wave Life Sciences Ltd., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., uniQure N.V., Prilenia Therapeutics B.V., Sage Therapeutics Inc., Annexon Inc., Alnylam Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Hikma Pharmaceuticals plc, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., AbbVie Inc.

Global Huntington’s Disease Treatment Market Trends and Insights

Major companies operating in the Huntington’s disease treatment market are focused on developing advanced therapies such as selective vesicular monoamine transporter 2 (VMAT2) inhibitor capsules to potentially improve patient quality of life while slowing disease progression. Selective VMAT2 inhibitor capsules are medications that block the vesicular monoamine transporter 2, a protein involved in packaging neurotransmitters for brain release. These drugs help reduce neurotransmitter release, aiding in the management of involuntary movements and related symptoms. For instance, in August 2023, Neurocrine Biosciences, Inc., a US-based biotech company, received approval from the U.S. Food and Drug Administration (FDA) for Ingrezza (valbenazine) capsules for the treatment of chorea associated with Huntington's disease (HD) in adults. These capsules are a once-daily oral VMAT2 inhibitor, working by reducing excessive dopamine signaling in the brain to help control involuntary movements. The medication is available in multiple capsule strengths and can be taken with or without food, offering a convenient dosing option for patients.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Huntington’s Disease Treatment Market?

In December 2024, PTC Therapeutics Inc., a US-based pharmaceutical company that is actively developing a treatment for Huntington’s disease, partnered with Novartis AG to provide a Huntington’s disease treatment. This partnership aims to accelerate the development and global commercialization of PTC518, a potential first-in-class oral, disease-modifying therapy for Huntington’s disease. Novartis AG is a Switzerland-based manufacturer of drugs for Huntington’s disease.

Regional Insights

North America was the largest region in the Huntington’s disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the huntington’s disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the huntington’s disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Huntington’s Disease Treatment Market?

The Huntington's disease treatment market consists of sales of products including tetrabenazine, deutetrabenazine, huntingtin-lowering therapies, cannabinoids, and cognitive enhancers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Huntington’s Disease Treatment Market Report 2026?

The huntington’s disease treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the huntington’s disease treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Huntington’s Disease Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.92 billion
Revenue Forecast In 2035 $1.48 billion
Growth Rate CAGR of 12.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Administration Type, Therapeutic, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Wave Life Sciences Ltd., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., uniQure N.V., Prilenia Therapeutics B.V., Sage Therapeu
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Huntington’s Disease Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Huntington’s Disease Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Huntington’s Disease Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Huntington’s Disease Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Focus On Disease-Modifying Therapies

4.2.2 Increasing Adoption Of Gene And Rna-Based Treatments

4.2.3 Expansion Of Combination Therapy Approaches

4.2.4 Rising Emphasis On Symptom-Specific Drug Development

4.2.5 Increasing Clinical Trial Activity For Rare Neurological Disorders

5. Huntington’s Disease Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Homecare Settings

5.4 Research Centers

5.5 Specialty Neurology Centers

6. Huntington’s Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Huntington’s Disease Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Huntington’s Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Huntington’s Disease Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Huntington’s Disease Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Huntington’s Disease Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Huntington’s Disease Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Huntington’s Disease Treatment Market Segmentation

9.1. Global Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Symptomatic Treatment, Disease-Modifying Therapies

9.2. Global Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Subcutaneous, Topical

9.3. Global Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Disorders, Neurological Disorders, Psychiatric Disorders

9.4. Global Huntington’s Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Huntington’s Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Homecare Settings, Research Centers

9.6. Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antidepressants, Antipsychotics, Mood Stabilizers, Chorea Medications, Cognitive Enhancers

9.7. Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Disease-Modifying Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gene Therapy, Neuroprotective Agents, RNA-Based Therapies, Stem Cell Therapy, Protein-Targeting Therapies

10. Huntington’s Disease Treatment Market Regional And Country Analysis

10.1. Global Huntington’s Disease Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Huntington’s Disease Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Huntington’s Disease Treatment Market

11.1. Asia-Pacific Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Huntington’s Disease Treatment Market

12.1. China Huntington’s Disease Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Huntington’s Disease Treatment Market

13.1. India Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Huntington’s Disease Treatment Market

14.1. Japan Huntington’s Disease Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Huntington’s Disease Treatment Market

15.1. Australia Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Huntington’s Disease Treatment Market

16.1. Indonesia Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Huntington’s Disease Treatment Market

17.1. South Korea Huntington’s Disease Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Huntington’s Disease Treatment Market

18.1. Taiwan Huntington’s Disease Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Huntington’s Disease Treatment Market

19.1. South East Asia Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Huntington’s Disease Treatment Market

20.1. Western Europe Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Huntington’s Disease Treatment Market

21.1. UK Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Huntington’s Disease Treatment Market

22.1. Germany Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Huntington’s Disease Treatment Market

23.1. France Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Huntington’s Disease Treatment Market

24.1. Italy Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Huntington’s Disease Treatment Market

25.1. Spain Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Huntington’s Disease Treatment Market

26.1. Eastern Europe Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Huntington’s Disease Treatment Market

27.1. Russia Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Huntington’s Disease Treatment Market

28.1. North America Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Huntington’s Disease Treatment Market

29.1. USA Huntington’s Disease Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Huntington’s Disease Treatment Market

30.1. Canada Huntington’s Disease Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Huntington’s Disease Treatment Market

31.1. South America Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Huntington’s Disease Treatment Market

32.1. Brazil Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Huntington’s Disease Treatment Market

33.1. Middle East Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Huntington’s Disease Treatment Market

34.1. Africa Huntington’s Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Huntington’s Disease Treatment Market, Segmentation By Treatment, Segmentation By Administration Type, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Huntington’s Disease Treatment Market Regulatory and Investment Landscape

36. Huntington’s Disease Treatment Market Competitive Landscape And Company Profiles

36.1. Huntington’s Disease Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Huntington’s Disease Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Huntington’s Disease Treatment Market Company Profiles

36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. H. Lundbeck A/S Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Neurocrine Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Huntington’s Disease Treatment Market Other Major And Innovative Companies

Wave Life Sciences Ltd., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., uniQure N.V., Prilenia Therapeutics B.V., Sage Therapeutics Inc., Annexon Inc., Alnylam Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Hikma Pharmaceuticals plc, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., AbbVie Inc.

38. Global Huntington’s Disease Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Huntington’s Disease Treatment Market

40. Huntington’s Disease Treatment Market High Potential Countries, Segments and Strategies

40.1 Huntington’s Disease Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Huntington’s Disease Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Huntington’s Disease Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Huntington’s Disease Treatment Market, Overview Of Key Products - Product Examples
  • Table 2: Global Huntington’s Disease Treatment Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Huntington’s Disease Treatment Market, Supply Chain Analysis
  • Table 4: Global Huntington’s Disease Treatment Market, Major Raw Material Providers
  • Table 5: Global Huntington’s Disease Treatment Market, Major Resource Providers
  • Table 6: Global Huntington’s Disease Treatment Market, Major Manufacturers (Suppliers)
  • Table 7: Global Huntington’s Disease Treatment Market, Major Distributors And Channel Partners
  • Table 8: Global Huntington’s Disease Treatment Market, Key Technologies & Future Trends
  • Table 9: Global Huntington’s Disease Treatment Market, Major Trends
  • Table 10: Global Huntington’s Disease Treatment Market, Major End Users
  • Table 11: Global Huntington’s Disease Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Huntington’s Disease Treatment Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Huntington’s Disease Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Huntington’s Disease Treatment Market - TAM, US$ Billion, 2025
  • Table 15: Global Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Huntington’s Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Huntington’s Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Disease-Modifying Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Huntington’s Disease Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Huntington’s Disease Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Huntington’s Disease Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Huntington’s Disease Treatment Market - Company Scoring Matrix
  • Table 98: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 99: Novartis AG Financial Performance
  • Table 100: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 101: H. Lundbeck A/S Financial Performance
  • Table 102: Neurocrine Biosciences Inc. Financial Performance
  • Table 103: Global Huntington’s Disease Treatment Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Huntington’s Disease Treatment Market, Competitive Dashboard
  • Table 105: Global Huntington’s Disease Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Huntington’s Disease Treatment Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 107: Global, Huntington’s Disease Treatment Market Size Gain ($ Billion), Segmentation By Administration Type, 2025 – 2030
  • Table 108: Global, Huntington’s Disease Treatment Market Size Gain ($ Billion), Segmentation By Therapeutic, 2025 – 2030

List Of Figures

    Figure 1: Global Huntington’s Disease Treatment Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Huntington’s Disease Treatment Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Huntington’s Disease Treatment Market, Supply Chain Analysis
  • Figure 4: Global Huntington’s Disease Treatment Market, Major Raw Material Providers
  • Figure 5: Global Huntington’s Disease Treatment Market, Major Resource Providers
  • Figure 6: Global Huntington’s Disease Treatment Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Huntington’s Disease Treatment Market, Major Distributors And Channel Partners
  • Figure 8: Global Huntington’s Disease Treatment Market, Key Technologies & Future Trends
  • Figure 9: Global Huntington’s Disease Treatment Market, Major Trends
  • Figure 10: Global Huntington’s Disease Treatment Market, Major End Users
  • Figure 11: Global Huntington’s Disease Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Huntington’s Disease Treatment Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Huntington’s Disease Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Huntington’s Disease Treatment Market - TAM, US$ Billion, 2025
  • Figure 15: Global Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Huntington’s Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Huntington’s Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Huntington’s Disease Treatment Market, Sub-Segmentation Of Disease-Modifying Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Huntington’s Disease Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Huntington’s Disease Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Huntington’s Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Huntington’s Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Huntington’s Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Huntington’s Disease Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Huntington’s Disease Treatment Market - Company Scoring Matrix
  • Figure 98: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 99: Novartis AG Financial Performance
  • Figure 100: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 101: H. Lundbeck A/S Financial Performance
  • Figure 102: Neurocrine Biosciences Inc. Financial Performance
  • Figure 103: Global Huntington’s Disease Treatment Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Huntington’s Disease Treatment Market, Competitive Dashboard
  • Figure 105: Global Huntington’s Disease Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Huntington’s Disease Treatment Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 107: Global, Huntington’s Disease Treatment Market Size Gain ($ Billion), Segmentation By Administration Type, 2025 – 2030
  • Figure 108: Global, Huntington’s Disease Treatment Market Size Gain ($ Billion), Segmentation By Therapeutic, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030...

Brain Monitoring Market Report 2026 - Global Outlook – By Product (Magnetoencephalograph, Electroencephalograph, Cerebral Oximeters, Intracranial Pressure Monitoring Devices), By Procedure (Invasive, Non-invasive), By Ap...

Brain Computer Interface Market Report 2026 - Global Outlook – By Type (Invasive Brain Computer Interface, Partially Invasive Brain Computer Interface, Non Invasive Brain Computer Interface, Other Types), By Component (H...

Brain Health Supplements Market Report 2026 - Global Outlook – By Product (Natural Molecules, Herbal Extract, Vitamins And Minerals), By Supplement Form (Tablets, Capsules, Liquid), By Distribution (Supermarket and Hyper...

Non-Invasive Brain Trauma Monitoring Devices Market Report 2026 - Global Outlook – By Type (Non-invasive Intracranial Pressure Monitor, Non-invasive Cerebral Edema Dynamic Monitor, Other Types), By Application (Traumatic...

Deep Brain Stimulation Device Market Report 2026 - Global Outlook – By Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), By Application (Epilepsy, Essential Tremor, Obsessive-Compul...

Brain Tumor Drugs Market Report 2026 - Global Outlook – By Drugs (Temozolomide, Bevacizumab, Other Drugs), By End User (Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other End-Users), By Mechanism of Action (Che...

Brain And Neuroimaging Devices Market Report 2026 - Global Outlook – By Imaging Type (Functional Magnetic Resonance Imaging (FMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EE...

Frequently Asked Questions

The Huntington’s Disease Treatment market was valued at $0.82 billion in 2025, increased to $0.92 billion in 2026, and is projected to reach $1.48 billion by 2030.

The global Huntington’s Disease Treatment market is expected to grow at a CAGR of 12.6% from 2026 to 2035 to reach $1.48 billion by 2035.

Some Key Players in the Huntington’s Disease Treatment market Include, F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., H. Lundbeck A/S, Neurocrine Biosciences Inc., Wave Life Sciences Ltd., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., uniQure N.V., Prilenia Therapeutics B.V., Sage Therapeutics Inc., Annexon Inc., Alnylam Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Hikma Pharmaceuticals plc, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., AbbVie Inc. .

Major trend in this market includes: Advancements In Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Therapies For Huntington's Disease Treatment. For further insights on this market. request a sample here

North America was the largest region in the Huntington’s disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the huntington’s disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us